Cite
Combination of miR159 Mimics and Irinotecan Utilizing Lipid Nanoparticles for Enhanced Treatment of Colorectal Cancer.
MLA
Yang, Rulei, et al. “Combination of MiR159 Mimics and Irinotecan Utilizing Lipid Nanoparticles for Enhanced Treatment of Colorectal Cancer.” Pharmaceutics, vol. 16, no. 4, Apr. 2024, p. 570. EBSCOhost, https://doi.org/10.3390/pharmaceutics16040570.
APA
Yang, R., Liu, Y., Yang, N., Zhang, T., Hou, J., He, Z., Wang, Y., Sun, X., Shen, J., Jiang, H., Xie, Y., & Lang, T. (2024). Combination of miR159 Mimics and Irinotecan Utilizing Lipid Nanoparticles for Enhanced Treatment of Colorectal Cancer. Pharmaceutics, 16(4), 570. https://doi.org/10.3390/pharmaceutics16040570
Chicago
Yang, Rulei, Yiran Liu, Ning Yang, Tian Zhang, Jiazhen Hou, Zongyan He, Yutong Wang, et al. 2024. “Combination of MiR159 Mimics and Irinotecan Utilizing Lipid Nanoparticles for Enhanced Treatment of Colorectal Cancer.” Pharmaceutics 16 (4): 570. doi:10.3390/pharmaceutics16040570.